FDA-cleared profile

Second Opinion CC

Pearl Inc.

Authorized purpose: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Product overview

Start with the essentials

Authorized purpose: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.

Overview status: Source-reviewed overview

Clinical takeaway

Clinical role: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.

Evidence takeaway

Evidence from the reviewed source record: K242522's 500-image standalone comparison evaluates caries localization by polygon contours versus the predicate's bounding boxes. Endpoint definitions, image mix, lesion count, and false-positive burden are retained so the 90% sensitivity is not interpreted in isolation.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Dental health professionals, including dentists, who review the radiograph, image findings, patient history, and in-vivo clinical assessment.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Care setting and population
Dental practices reviewing eligible permanent-tooth bitewing and periapical radiographs for patients aged 19 years or older.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Cloud-processed caries detection and localization as a second reader, with editable findings rendered in the client interface; final diagnosis and treatment decisions remain with the dentist.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Digital intraoral bitewing and periapical radiographs of permanent teeth in patients aged 19 years or older, sent through the application programming interface for cloud processing.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Output and human action
Machine-generated detection metadata rendered as editable polygonal overlays on the original radiograph to identify teeth and suspected carious lesions requiring clinical review.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Exact K242522 labeling is limited to caries contouring on bitewing and periapical permanent-tooth radiographs for patients 19 years or older. It does not establish panoramic use or detection of the broader findings advertised for the current Second Opinion family. False positives and false negatives remain possible, and a complete dentist review is required.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242522
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Dental/Maxillofacial
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-01-16
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The exact device contains an API, machine-learning modules, and a client interface: images and metadata pass through the API to cloud-based processing and detections return as metadata for interface rendering. Exact connectors and supported practice systems are not listed in the FDA summary.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Deployment and data flow
Cloud-based processing with a Windows client environment, as described in the exact FDA substantial-equivalence comparison.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Current hosting region, tenancy, retention, service levels, and exact client requirements require vendor confirmation.

Security and privacy
The exact FDA summary states that Pearl developed security controls and development/postmarket processes using the FDA's September 2023 premarket cybersecurity guidance and December 2016 postmarket cybersecurity guidance. It does not disclose the control scope, audit evidence, data flow, retention, or assurance period needed for procurement.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Training and support
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

Role-based onboarding, clinical-use training, competency assessment, support terms, and retraining after updates were not established.

Monitoring and change control
Monitor patient-age and image-type eligibility, upload and processing failures, result latency, contour edits, false positives per image, false-negative review, dentist/AI disagreement, downstream treatment acceptance, update control, complaints, cybersecurity events, and exact-submission recalls.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Buyer acceptance guidance derived from the exact workflow, risk description, and performance endpoints; it is not a claimed vendor monitoring service.

Exact API-to-client workflow

The exact submission describes an API that routes image data to cloud machine-learning modules and returns detection metadata to a Windows client for editable polygon rendering.

exact submission · checked 2026-09-08

Current Second Opinion family integrations

Pearl's current Second Opinion page describes native integrations with more than 40 imaging and practice-management systems plus a standalone web app, with vendor-led setup. This is family context and does not establish connector or feature availability for the exact K242522 configuration.

product family · checked 2026-09-08

Current family processing workflow

Pearl's current page says most current-family images load in under one minute and includes bitewing, periapical, and panoramic workflows across many findings. Only the exact K242522 caries, bitewing/periapical, permanent-teeth, and age-19+ scope is applicable to this dossier.

product family · checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K242522's 500-image standalone comparison evaluates caries localization by polygon contours versus the predicate's bounding boxes. Endpoint definitions, image mix, lesion count, and false-positive burden are retained so the 90% sensitivity is not interpreted in isolation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Lesion-level sensitivity 90% (95% CI 87%-94%) at Jaccard index 0.4
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Weighted alternative free-response ROC figure of merit

0.81 wAFROC FOM

  • EndpointCaries localization non-inferiority using polygonal contours at Jaccard index 0.4
  • Population500 dental radiographs: 249 periapical and 251 bitewing; 212 contained caries and 356 ground-truth lesions were marked
  • Tested versionSecond Opinion CC caries-contouring configuration described in K242522

Highest-rated ROC area under curve

0.88 HR-ROC AUC

  • EndpointSecondary caries-detection comparison against polygonal consensus ground truth
  • Population500 dental radiographs: 249 periapical and 251 bitewing
  • Tested versionSecond Opinion CC caries-contouring configuration described in K242522

Lesion-level sensitivity

90 percent

  • EndpointCaries lesion localization with overlap at or above Jaccard index 0.4
  • Population500 radiographs containing 356 ground-truth caries lesions across 212 abnormal images
  • Tested versionSecond Opinion CC caries-contouring configuration described in K242522

Average false positives per image

1.34 false positives per image

  • EndpointPredicted regions without ground-truth overlap at or above Jaccard index 0.4
  • Population500 dental radiographs
  • Tested versionSecond Opinion CC caries-contouring configuration described in K242522

K242522 Second Opinion CC standalone non-inferiority study

  • DesignStandalone non-inferiority comparison of polygonal Second Opinion CC with the bounding-box Second Opinion predicate using four-reader consensus ground truth and wAFROC as the primary efficacy paradigm.
  • Population500 images: 249 periapical and 251 bitewing; 212 caries-positive images with 356 lesions. The age metadata included 9 images from ages 12-18, 233 from ages 18-75, 13 from ages 75+, and 245 with unknown age despite labeling for patients 19 years or older.
  • Scopeexact submission
  • Tested versionSecond Opinion CC caries-contouring configuration described in K242522
  • Samplen=500
  • IndependenceSponsor or vendor study

K242522

Manufacturer-submitted regulatory evidence. The age-distribution mismatch and large unknown-age share should be addressed during local evidence review; the FDA summary does not provide a subgroup result for the labeled 19+ population.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-08

No public exact-product amount, pricing unit, term, minimum, implementation fee, or support inclusion was established.

Reimbursement and coding
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-08

Pearl's patient-facing blog says AI is typically not separately billed, but it is not payer policy and does not establish product reimbursement or underlying-service coverage.

No product-specific code

Pearl states in a patient-facing article that AI analysis is typically incorporated into routine dental diagnostic care and not billed separately; this is a vendor generalization, not an exact-product payer policy or coverage determination.

General dental insurance context stated by Pearl · United States

Do not infer reimbursement, patient cost, or contract pricing. Verify each payer, plan, underlying exam/X-ray benefit, provider agreement, and billing practice.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-submission FDA recall query returned no native recall record for K242522. This limited query does not establish absence of recalls or other safety information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-08Last searched
25Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored PubMed and ClinicalTrials.gov candidate arrays were empty. No paper or trial was promoted; empty arrays do not establish absence of external evidence. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor patient education, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. K242522 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Second Opinion CC model card (K242522)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: purpose, modality, intendedUsers, careSetting, output, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. FDA 510(k) K242522: Second Opinion CC

    U.S. Food and Drug Administration - Published 2025-01-16 - Accessed 2026-09-07

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, security

  8. Second Opinion real-time dental pathology detection

    Pearl, Inc. - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow, integrations, implementationCapabilities

  9. Dental check-up appointment with AI: cost and insurance considerations

    Pearl, Inc. - Published 2026-03-02 - Accessed 2026-09-08

    Scope: vendorEconomicsContext, patientFees, insuranceContext

  10. openFDA exact recall query for K242522

    U.S. Food and Drug Administration - Accessed 2026-09-07

    Scope: postmarketSafety

Research history

  1. K242522 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251002

Videa Dental AI

VideaHealth Inc.

Analyzes bitewing, periapical, and panoramic intraoral radiographs from patients aged 3 years and older to identify and localize specified suspected dental findings, historical...

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-09-19
FDA-cleared K252086

DTX Studio Assist

Nobel Biocare C/O Medicim NV

Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency,...

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-17
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring...

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07
FDA-cleared K250753

VELMENI for DENTISTS (V4D)

Velmeni Inc.

Assists dentists in detecting caries, fillings/restorations, fixed prostheses, and implants on digital bitewing, periapical, and panoramic radiographs of permanent teeth in...

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-09-02